Prospective Study on COVID -19 Reinfection on Vaccinated and Non-vaccinated Outpatients
NCT ID: NCT06544369
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2021-11-20
2022-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Covid-19 Infection in After Vaccination
NCT05033834
Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians
NCT04706143
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991
Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
NCT05078905
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
NCT05160636
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vaccinated group
all criteria are accepted for study
COVID-19 vaccin
injection
Non-vaccinated group
all criteria are accepted for study
COVID-19 vaccin
injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID-19 vaccin
injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* take any type of vaccines
Exclusion Criteria
* not vaccinated with COVID vaccine
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Soad Ali
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soad Ali
lecturer of pharmaceutics and clinical pharmacy Deraya university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deraya university
Minya, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Deraya university
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.